NDLI: Assessing the role of adolescent hormonal contraceptive use on risk for depression: a 3-year longitudinal study protocol

Content Provider	Springer Nature : BioMed Central
Author	Zareian, Bita Anderl, Christine LeMoult, Joelle Galea, Liisa A. M. Prior, Jerilynn C. Rights, Jason D. Ross, Colin J. Ge, Sabrina Hayward, Annie C. Chen, Frances S.
Abstract	Background The incidence of depression in human females rises steadily throughout adolescence, a critical period of pubertal maturation marked by increasing levels of gonadal hormones including estrogens and progesterone. These gonadal hormones play a central role in social and emotional development and may also contribute to the increased occurrence of depression in females that begins in early adolescence. In this study, we examine whether and how introducing synthetic estrogen and progestin derivatives through the use of combined hormonal contraceptives (CHC), affects adolescent females’ risk for developing depression. We further assess potential links between CHC use and alterations in stress responses and social-emotional functioning. Methods Using a longitudinal cohort design, we will follow a sample of adolescent females over the span of three years. Participants will be assessed at three time points: once when they are between 13 and 15 years of age, and at approximately 18 and 36 months after their initial assessment. Each time point will consist of two online sessions during which participants will complete a clinical interview that screens for key symptoms of mental health disorders, along with a series of questionnaires assessing their level of depressive symptoms and history of contraceptive use. They will also complete a standardized social-evaluative stress test and an emotion recognition task, as well as provide saliva samples to allow for assessment of their circulating free cortisol levels. Discussion In this study we will assess the effect of CHC use during adolescence on development of Major Depressive Disorder (MDD). We will control for variables previously found to or proposed to partially account for the observed relationship between CHC use and MDD, including socioeconomic status, age of sexual debut, and CHC-related variables including age of first use, reasons for use, and its duration. In particular, we will discover whether CHC use increases depressive symptoms and/or MDD, whether elevated depressive symptoms and/or MDD predict a higher likelihood of starting CHC, or both. Furthermore, this study will allow us to clarify whether alterations in stress reactivity and social-emotional functioning serve as pathways through which CHC use may result in increased risk of depressive symptoms and/or MDD.
Related Links	https://bmcwomenshealth.biomedcentral.com/counter/pdf/10.1186/s12905-022-01623-2.pdf
Ending Page	13
Page Count	13
Starting Page	1
File Format	HTM / HTML
ISSN	14726874
DOI	10.1186/s12905-022-01623-2
Journal	BMC Women's Health
Issue Number	1
Volume Number	22
Language	English
Publisher	BioMed Central
Publisher Date	2022-02-23
Access Restriction	Open
Subject Keyword	Gynecology Maternal and Child Health Reproductive Medicine Birth control Stress reactivity Cortisol Puberty Emotional development Social functioning Major depressive disorder Mood disorder Mental health
Content Type	Text
Resource Type	Article
Subject	Obstetrics and Gynecology Reproductive Medicine
Journal Impact Factor	2.4/2023
5-Year Journal Impact Factor	2.9/2023

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

The mothers, Omega-3 and mental health study

Depression

A DSM-5-based tool to monitor concurrent mood and premenstrual symptoms: the McMaster Premenstrual and Mood Symptom Scale (MAC-PMSS)

Effects of prenatal depressive symptoms on maternal and infant cortisol reactivity

Assessing the impact of contraceptive use on mental health among women of reproductive age – a systematic review

Trajectories of maternal depressive and anxiety symptoms from pregnancy to five years postpartum and their prenatal predictors

Migraine associated with early onset postpartum depression in women with major depressive disorder.

Emotions in Depression: What Do We Really Know?

Perinatal maternal depression and cortisol function in pregnancy and the postpartum period: a systematic literature review

Assessing the role of adolescent hormonal contraceptive use on risk for depression: a 3-year longitudinal study protocol

Similar Documents

The mothers, Omega-3 and mental health study

Depression

A DSM-5-based tool to monitor concurrent mood and premenstrual symptoms: the McMaster Premenstrual and Mood Symptom Scale (MAC-PMSS)

Effects of prenatal depressive symptoms on maternal and infant cortisol reactivity

Assessing the impact of contraceptive use on mental health among women of reproductive age – a systematic review

Trajectories of maternal depressive and anxiety symptoms from pregnancy to five years postpartum and their prenatal predictors

Migraine associated with early onset postpartum depression in women with major depressive disorder.

Emotions in Depression: What Do We Really Know?

Perinatal maternal depression and cortisol function in pregnancy and the postpartum period: a systematic literature review

Assessing the role of adolescent hormonal contraceptive use on risk for depression: a 3-year longitudinal study protocol